A naturally-occurring protein in the human body could protect people from one of the world’s biggest killers – sepsis. The ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

A naturally occurring protein in the human body could protect people from one of the world's biggest killers—sepsis. The ...

PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specializing in immunotherapies for acute and chronic inflammatory syndromes, disclosed for the first time today at the ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

The NQF issued this statement when reached for comment Tuesday: "NQF's Patient Safety Measures Standing Committee is empanelled and will conduct an ad hoc review of this measure as a result of this ...

Leukopenia may be seen in sepsis as one of the systemic inflammatory response syndrome (SIRS) criteria, ie, white blood cell count below 4000, and may portend a poor prognosis. But severe leukopenia, ...

Sepsis has made headlines this week around the world following the quadruple amputation of a Birmingham woman. Here’s what ...

Sepsis is a medical emergency. It can lead to organ failure and death. The earlier a person receives treatment, the more likely they are to survive. Sepsis occurs when the immune system has an extreme ...